Gossamer Bio
Price & Volume
Stats
See more52W Range | $9.12-$309.60 |
Market Cap | $56.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $53.2M |
Revenue Growth (YoY) | -19.6% |
Gross Profit (12 Mos) | $53.2M |
Diluted EPS | -$52.80 |
News
See moreYahoo Finance • last month
Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
Yahoo Finance • 2 months ago
Gossamer Bio announces $250m in funding to advance seralutinib
Yahoo Finance • 2 months ago
Sector Update: Healthcare Stocks Advance in Afternoon Trading
Yahoo Finance • 2 months ago
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
About
CEO | Mr. Faheem Hasnain |
CFO | Mr. Bryan Giraudo |
Address | 3115 Merryfield Row, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |